Deerfield Management Reports New Stake in KaloBios Pharmaceuticals Inc (KBIO)

James E. Flynn‘s Deerfield Management has reported adding KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) to its equity portfolio. Deerfield currently holds around 3.18 million shares of the company, the passive stake amassing 9.64% of the common stock.

KaloBios Pharmaceuticals

KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) is a U.S.-based bio-therapeutic company, which is engaged in development of protein therapeutics. About a week ago, the company reported that its Phase 2 study of a monoclonal antibody for patients with severe asthma. The study was well tolerated but it didn’t meet its clinical endpoints. Amid the news, the stock of the company dropped by over 18% in the past several days, and overall, it lost almost 40% since the beginning of the year.

The analysts consider KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)’s stock being “overweight” and set a target price of $9.00 per share, well above the current price of the stock. At the same time, the company has missed the estimates for its net income for the last several quarters.

Despite the poor performance of the company, investors seem to be bullish on KaloBios Pharmaceuticals Inc (NASDAQ:KBIO). In the previous round of 13F filings, several funds disclosed holding shares of KaloBios with many initiating their positions during the third quarter of 2013. Jean-Marie Eveillard‘s First Eagle Investment Management reported ownership of 875,000 shares, followed by Clough Capital Partners, led by Charles Clough, and Charles Davidson‘s Wexford Capital, with 400,000 and 278,500 shares respectively.

Deerfield reported the new stake added to its equity portfolio only a day after disclosing holding shares of Auspex Pharmaceuticals Inc (NASDAQ:ASPX), and Dicerna Pharmaceuticals Inc (NASDAQ:DRNA). Both companies went public recently and Deerfield reported holding significant amounts of shares in both of them.

Disclosure: none

Recommended Reading:

Hedge Fund Highlights: Warren Buffett, Bill Ackman & Richard Gerson

Becker Drapkin Ups Stake in Nano-Cap Special Diversified Opportunities Inc (SDOI)

Iroquois Capital Management Sends Letter to MGT Capital Investments Inc. (MGT) Board

Dividend Stock Alert - Billionaire Robbins' Top Dividend Idea With 70% Upside Potential

Get Paid 3.5% Per Year While Waiting For The Stock Appreciate 70%

Larry Robbins' Glenview Capital Opportunity Fund returned 101.7% in 2013 and Robbins personally made $750 million. The same fund returned 25.3% in 2014. In this FREE REPORT we will share Robbins' top dividend idea that yields 3.5% and has been increasing its dividends for 39 consecutive years. Robbins thinks the stock has the potential to appreciate 70%.

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!